Advertisement
Screener

NUTRA PHARMA CORP. (NPHC) Gain (Loss) on Sale of Derivatives

NUTRA PHARMA CORP. Gain (Loss) on Sale of Derivatives

NUTRA PHARMA CORP. (NPHC) reported Gain (Loss) on Sale of Derivatives of $22.58 thousand for the 12-month period ending 2011-12-31, per its 10-K/A filed 2012-11-15.

Discontinued › Income Statement › Other Income

us-gaap:GainLossOnSaleOfDerivatives · last filed 2012-11-15

  • NUTRA PHARMA CORP. gain (loss) on sale of derivatives for fiscal 2011 was $22.58K.
  • NUTRA PHARMA CORP. gain (loss) on sale of derivatives for fiscal 2010 was -$90.50K.
Period endGain (Loss) on Sale of Derivatives 12 month
2011-12-31$22.58K
10-K/A · filed 2012-11-15
2010-12-31-$90.50K
10-K/A · filed 2012-11-15